L-Homocystine - Endogenous Metabolite - 生命科學(xué)試劑 - MedChemExpress_第1頁
L-Homocystine - Endogenous Metabolite - 生命科學(xué)試劑 - MedChemExpress_第2頁
L-Homocystine - Endogenous Metabolite - 生命科學(xué)試劑 - MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEL-HomocystineCat. No.: HY-W011690CAS No.: 626-72-2分式: CHNOS分量: 268.35作靶點(diǎn): Endogenous Metabolite作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 1 mg/mL (3.73 mM

2、; ultrasonic and adjust pH to 5 with HCl)H2O : 1 mg/mL (3.73 mM; ultrasonic and adjust pH to 2 with HCl)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 3.7265 mL 18.6324 mL 37.2648 mL5 mM - - -10 mM - - -請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 L-HomocystineL-homocystein

3、e 的種氧化物,L-homocysteine 種抗栓因,管舒張損害劑,促炎因,也 研究管疾病發(fā)機(jī)制的內(nèi)質(zhì)應(yīng)激反應(yīng)的誘導(dǎo)劑。IC50 & Target Human Endogenous Metabolite體內(nèi)研究A single or multiple doses of L-Homocystine administered to mice during organogenesis can aggravate the1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEdevelopmental disturbances caused by a sin

4、gle dose of VPA administered on GD 8. Whereas, VPA lowerssignificantly plasma FA and vitamin B12 concentrations, it has no direct impact on the homocysteineconcentrations. Therefore, it is proposed that high levels of homocysteine disturb the FA, vitamin B12, andpossibly methionine metabolism thus p

5、roviding a favorable situation for VPA to interfere with thedevelopment of susceptible embryos 1.PROTOCOLAnimal Mice 1Administration 1 Groups of mice are first injected on GD 8 with a single dose of 75 mg/kg of L-Homocystine or an equalvolume of saline. One half of the L-Homocystine-treated animals

6、then receive a single dose of 600 mg/kg ofVPA (H-HoCys-OH)2+VPA group), while the other half are injected with a proportionate volume of saline (L-Homocystine+saline group). In the other experiment, mice are treated with a daily dose of 75 mg/kg of L-Homocystine or a proportionate volume of saline s

7、tarting from GD 5 and continue through GD 10. One half ofthe L-Homocystine-treated animals also have a single exposure to 600 mg/kg of VPA (L-Homocystine+VPAgroup) or a proportionate volume of saline (L-Homocystine+saline group) on GD 8. The total volume of fluidinjected corresponded to the body wei

8、ght and does not exceed 0.45 mL 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Padmanabhan R, et al. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouseembryos. Eur J Nutr. 2006 Sep;45(6):311-9McePdfHeightCaution: Product has not been fully validated for medical application

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論